Three-Dimensional Bioprinting of Organoid-Based Scaffolds (OBST) for Long-Term Nanoparticle Toxicology Investigation

Abstract

The toxicity of nanoparticles absorbed through contact or inhalation is one of the major concerns for public health. It is mandatory to continually evaluate the toxicity of nanomaterials. In vitro nanotoxicological studies are conventionally limited by the two dimensions. Although 3D bioprinting has been recently adopted for three-dimensional culture in the context of drug release and tissue regeneration, little is known regarding its use for nanotoxicology investigation. Therefore, aiming to simulate the exposure of lung cells to nanoparticles, we developed organoid-based scaffolds for long-term studies in immortalized cell lines. We printed the viscous cell-laden material via a customized 3D bioprinter and subsequently exposed the scaffold to either 40 nm latex-fluorescent or 11–14 nm silver nanoparticles. The number of cells significantly increased on the 14th day in the 3D environment, from 5 × 105 to 1.27 × 106, showing a 91% lipid peroxidation reduction over time and minimal cell death observed throughout 21 days. Administered fluorescent nanoparticles can diffuse throughout the 3D-printed scaffolds while this was not the case for the unprinted ones. A significant increment in cell viability from 3D vs. 2D cultures exposed to silver nanoparticles has been demonstrated. This shows toxicology responses that recapitulate in vivo experiments, such as inhaled silver nanoparticles. The results open a new perspective in 3D protocols for nanotoxicology investigation supporting 3Rs.

Surgical Medical Education via 3D Bioprinting: Modular System for Endovascular Training

“…The material is deposited layer-by-layer, enabling the ability to create objects with complex shapes not attainable with typical material subtraction manufacturing processes. At the same time, 3D printing utilizes only the required material, reducing waste and pollution [25]. Bioprinting identifies all AM processes that aim to combine cells, growth factors, and/or biomaterials to fabricate biomedical parts, frequently to achieve characteristics that mimic natural tissue or its morphology, enabling the rapid customization of personalized devices and/or drugs to support tissue functionality restoration.…”

(3D) Bioprinting—Next Dimension of the Pharmaceutical Sector

“…Choi and colleagues employed a three-dimensional (3D) tumor model to identify the most effective drug for combating lung cancer cells [ 45 ]. In a study of Gerbolés, the OBST (organoid-based frameworks for toxicological examination) procedure demonstrated a few points of interest for nanotoxicology/nanomedical examination as follows: cells can survive longer without sections; nanoparticles can spread and diffuse within the cell-laden multilayer by mirroring the in vivo introduction; and nanoparticles reach the 3D-printed cells in all layers with a discernible increase in internalization [ 46 ]. Amid the COVID-19 pandemic caused by SARS-CoV-2 in 2020, in the midst of a worldwide race to combat the disease’s movement, OoCs were considered for treatment purposes, giving rise to fast and dependable preclinical outcomes [ 47 ].…”

The Upper Limb Orthosis in the Rehabilitation of Stroke Patients: The Role of 3D Printing

“…Finally, to produce living tissue and organ bioprinting requires the combination of biological/synthetic materials [67][68][69], enabling the bioplotting of organoids by adding cells into the bio-ink [70,71].…”